Trial Details
Not RecruitingBasic Information
| Clinical ID | c2754 |
|---|---|
| Identifier | EUCTR2017-005059-10-BE |
| Trial Title | Multicentric, double-blind, placebo controlled clinical trial with 5-hydroxytryptophan (5-HTP) in patients with inflammatory bowel disease in clinical and biologic remission: effect on fatigue scores - Trp-IBD |
| Trial URL | Visit Original Page |
Study Information
| Study Results | No results available |
|---|---|
| Conditions | Inflammatory Bowel Disease (IBD);Therapeutic area: Diseases [C] - Digestive System Diseases [C06] |
| Interventions | Trade Name: Levotonine Pharmaceutical Form: Capsule INN or Proposed INN: OXITRIPTAN CAS Number: 4350-09-8 Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 100- Pharmaceutical form of the placebo: Capsule Route of administration of the placebo: Oral use |
Participant Information
| Sponsor | Ghent University Hospital |
|---|---|
| City | - |
| Country/Region | Belgium |
Enrollment Criteria
| Sex Requirement | NOT SPECIFIED |
|---|---|
| Age Requirement | - |
Study Design
| Study Type | Interventional clinical trial of medicinal product |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2025-04-24 |
|---|---|
| Primary Completion Date | - |
| Completion Date | - |